Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Alternative Investment Advisors LLC.

Alternative Investment Advisors LLC. reduced its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 4.7% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 12,429 shares of the company’s stock after selling 617 shares during the period. Alternative Investment Advisors LLC.’s holdings in Doximity were worth $542,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in DOCS. SG Americas Securities LLC lifted its position in Doximity by 29.6% during the 2nd quarter. SG Americas Securities LLC now owns 16,033 shares of the company’s stock worth $448,000 after acquiring an additional 3,659 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Doximity by 621.4% during the second quarter. Blue Trust Inc. now owns 1,385 shares of the company’s stock worth $37,000 after purchasing an additional 1,193 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Doximity by 15,714.3% during the second quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock worth $310,000 after purchasing an additional 11,000 shares in the last quarter. First Horizon Advisors Inc. boosted its stake in shares of Doximity by 80.0% in the second quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company’s stock valued at $48,000 after purchasing an additional 760 shares during the period. Finally, Fifth Third Bancorp grew its holdings in Doximity by 181.6% during the 2nd quarter. Fifth Third Bancorp now owns 3,207 shares of the company’s stock valued at $90,000 after purchasing an additional 2,068 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Morgan Stanley raised shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. Robert W. Baird raised their price objective on Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Evercore ISI increased their target price on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and lifted their price target for the stock from $40.00 to $60.00 in a research note on Wednesday, November 13th. Finally, Raymond James reiterated an “outperform” rating and set a $65.00 price objective (up from $37.00) on shares of Doximity in a research note on Friday, November 8th. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $52.44.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded down $0.30 during trading on Friday, reaching $52.40. The company had a trading volume of 153,442 shares, compared to its average volume of 1,745,013. The firm’s fifty day moving average is $47.88 and its 200 day moving average is $37.71. The firm has a market capitalization of $9.78 billion, a PE ratio of 57.74, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.